News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Single fraction RT as an effective palliative treatment for painful liver cancer
Sep 13, 2024, 14:06

Single fraction RT as an effective palliative treatment for painful liver cancer

David Kirsch, Radiation Oncologist at Princess Margaret Cancer Centre, shared on X:

” Congratulations Laura Dawson, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Radiation Oncology and colleagues across Canada for publishing CCTG HE1 in The Lancet Oncology

establishing single fraction RT as an effective palliative treatment for painful liver cancer.”

Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study

Authors: Prof Laura A Dawson, Prof Jolie Ringash, Alysa Fairchild, Paul Stos, Kristopher Dennis, Aamer Mahmud, Teri Lynn Stuckless, Francois Vincent, Prof David Roberge, Matthew Follwell, Raimond K W Wong, Derek J Jonker, Prof Jennifer J Knox, Prof Camilla Zimmermann, Philip Wong, Prof Aisling S Barry, Marc Gaudet, Prof Rebecca K S Wong, Thomas G Purdie, Prof Dongsheng Tu, Prof Christopher J O’Callaghan.

Single fraction RT as an effective palliative treatment for painful liver cancer
Aamer Mahmud Alysa Fairchild cancer Derek J. Jonker Francois Vincent Kristopher Dennis Laura Dawson Marc Gaudet Matthew Follwell OncoDaily Oncology Paul Stos Philip Wong Princess Margaret Cancer Centre Prof Aisling S Barry Prof Camilla Zimmermann Prof Christopher J O'Callaghan Prof David Roberge Prof Dongsheng Tu Prof Jennifer J Knox Prof Jolie Ringash Prof Laura A Dawson Prof Rebecca K S Wong Radiation Medicine Program radiation oncology Raimond K W Wong Teri Lynn Stuckless The Lancet Oncology Thomas G Purdie University Health Network
Special Coverage
Insight
May 9, 2025, 13:17
Angelo Dipasquale: Exploring the Role of ADCs in CNS malignancies and Primary Brain Tumors
Insight
May 9, 2025, 13:06
Sampson Chinonso Ipiankama: The Role of Men in Early Care-seeking for Ovarian Cancer in LMICs
Insight
May 9, 2025, 13:01
Ahmed Alanazi: T-DXd Achieves Primary Endpoint in Early Breast Cancer Neoadjuvant Trial (DB-11)
Science
May 9, 2025, 12:49
The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia
Drugs
May 9, 2025, 12:42
Penpulimab: What patients need to know?
Blog
May 9, 2025, 12:36
Avisek Banerjee: Proud to support Triparna Sen for 2025 IASLC Board of Directors (Basic Science) ballot
Science
May 9, 2025, 12:28
Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma
Blog
May 9, 2025, 12:26
Caryn Lerman: Join us for the 3rd Annual Cancer Research Day
Blog
May 9, 2025, 12:18
Navneet Singh: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening
Blog
May 9, 2025, 12:14
Aakash Desai Highlights New Study on BRAF-Mutated NSCLC: Personalization Over One-Size-Fits-All
History
May 9, 2025, 11:55
Celebrating AACR's Founding Anniversary - From 11 Prominent Scientists to 59,000 Research Leaders
Blog
May 9, 2025, 11:53
Amol Akhade Discusses POTOMAC Phase 3 Results in High-Risk NMIBC